Skip to main content
Premium Trial:

Request an Annual Quote

Leonardo Receives Second Half of $2.5M Grant

Premium

Leonardo Biosystems said this week that it has received the second half of a $2.5 million grant from the Texas Emerging Technology Fund to help develop its multi-stage drug-delivery technology.

The first half of the grant was received in April 2010.

The drug-delivery technology involves a multi-stage system comprising mesoporous silicon particles containing neutral nanoliposomes carrying a drug payload.

Last year, Gene Silencing News reported that the company was aiming to use the grant funding to help ramp up its operations so that it could establish industry partnerships (GSN 10/27/2010).

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.